Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > FDA

<< Previous

Bullboard Posts

Next >>

Comment by Starkickeron Nov 28, 2022 1:40pm

79 Views

Post# 35134340

RE:RE:RE:FDA

Just playing the devil's advocate (again) but to access the NASDAQ this is going to require at least a 40:1 reverse split (likely higher). It would be great to grow the SP organically to get there but the timing will be way off and revenue won't grow that fast. Probably why tthe outlook looks so good but SP isn't climbing. If you want to know what a reverse split does to a stock just look at ACB, ELBM or MMED histories. Early investors are sacrificed.

<< Previous

Bullboard Posts

Next >>

Desert Gold Ventures - A jewel for the investor?